Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia
ESICM Talk19 Tammi 2022

Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia

Systemic corticosteroids decrease mortality in critically ill patients with COVID-19, and the World Health Organization, therefore, recommends dexamethasone 6 mg daily for up to 10 days for patients with severe or critical COVID-19. In addition, higher doses of systemic corticosteroids have been used in patients with COVID-19 and non-COVID-19 acute respiratory distress syndrome [3, 5, 6], and higher doses have been hypothesised to benefit patients with severe or critical COVID-19. However, the balance between benefit and harm remains uncertain.

The COVID STEROID 2 trial compared a higher (12 mg) versus recommended dose (6 mg) of dexamethasone daily, for up to 10 days, in patients with COVID-19 and severe hypoxaemia.

Dr Granholm was interviewed by ICM Associate Editor Dr Shankar-Hari about the methodology and the findings of the study.

Original paper: Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trial

Speakers

Anders GRANHOLM. Department of Intensive Care, Rigshospitalet—Copenhagen University Hospital (DK) and Collaboration for Research in Intensive Care (CRIC), Copenhagen (DK).

Manu SHANKAR-HARI. Usher Institute, University of Edinburgh (UK) and Centre for Inflammation Research, University of Edinburgh (UK)and School of Immunology and Microbial Sciences, King's College London, (UK). ICM Associate Editor.

Jaksot(90)

Life after sepsis in adult and paediatric patients

Life after sepsis in adult and paediatric patients

Sepsis is a life-threatening acute organ dysfunction secondary to infection and affects more than 19 million people annually. In 2017, it was estimated that almost 49 million people were infected by s...

13 Syys 202325min

Severe meningoencephalitis in the ICU: results from the EURECA study

Severe meningoencephalitis in the ICU: results from the EURECA study

Central nervous system (CNS) infections significantly burden ICU physicians' daily clinical work. Diagnosis can be challenging, and timely management is of the utmost importance. Meningoencephalitis i...

6 Syys 202318min

Diabetes mellitus in old critically ill COVID-19 patients

Diabetes mellitus in old critically ill COVID-19 patients

Several studies have found an association between diabetes mellitus, disease severity and outcome in COVID-19 patients. Old, critically ill patients are particularly at risk. A recent multicentre inte...

30 Elo 202310min

Results from the TAME trial

Results from the TAME trial

International guidelines recommend targeting normocapnia in adults with coma resuscitated after out-of-hospital cardiac arrest. However, normocapnia may be insufficient to restore and maintain adequat...

27 Kesä 202325min

Guidelines for the management of severe community-acquired pneumonia

Guidelines for the management of severe community-acquired pneumonia

Severe community‐acquired pneumonia (sCAP) is a clinical entity to describe ICU-admitted patients with community‐acquired pneumonia (CAP) as they might require organ support, and it is associated with...

24 Touko 202320min

Permissive azotemia during AKI enables more rapid renal recovery and less renal fibrosis

Permissive azotemia during AKI enables more rapid renal recovery and less renal fibrosis

Preclinical models of acute kidney injury (AKI) consistently demonstrate that a uremic milieu enhances renal recovery and decreases kidney fibrosis. Reduced renal clearance has the surprising and count...

17 Touko 202343min

How to manage coagulopathies in critically ill patients

How to manage coagulopathies in critically ill patients

Coagulopathy is a severe and frequent complication in critically ill patients, for which the pathogenesis and presentation may be variable depending on the underlying disease. Therefore, a review has ...

10 Touko 202320min

End of Life Care concepts in intensive care

End of Life Care concepts in intensive care

End-of-life care is an approach to a terminally ill patient that shifts the focus of care to symptom control, comfort, dignity, quality of life, and quality of dying rather than treatments aimed at cu...

3 Touko 202330min

Suosittua kategoriassa Liike-elämä ja talous

sijotuskasti
mimmit-sijoittaa
psykopodiaa-podcast
rss-rahapodi
rss-draivi
rss-rahamania
ostan-asuntoja-podcast
rss-sami-miettinen-neuvottelija
pomojen-suusta
inderespodi
rss-seuraava-potilas
herrasmieshakkerit
taloudellinen-mielenrauha
oppimisen-psykologia
rss-h-asselmoilanen
rss-paasipodi
rss-inderes
asuntoasiaa-paivakirjat
rss-lahtijat
rss-bisnesta-bebeja